Risks of interval colorectal cancer in a FIT-based screening program

Slides:



Advertisements
Similar presentations
A Quality Colonoscopy: Are You Providing One?
Advertisements

Colorectal Cancer Screening and Surveillance FDA Advisory Committee March, 2002 David Lieberman MD Chief, Division of Gastroenterology Oregon Health Sciences.
The Adenoma/Carcinoma Sequence in the Colon
EQUIP Training session 1
Surveillance colonoscopy after polypectomy – how frequent? Dr Chu Ming Leong Tuen Mun Hospital 1.
Update on Screening of Gastrointestinal Diseases Niraj Jani, M.D. Greater Baltimore Medical Center 1/30/15.
Multitarget Stool DNA Testing for Colorectal-Cancer Screening NEJM April 3, 2014 Vol 3 Imperiale, T.F. et al Presented by Melissa Spera, MD.
DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 
Colorectal Cancer Screening & Surveillance: Anything New? Timothy C. Hoops, M.D.
When Is A Colonoscopy Not a Colonoscopy
Joint Hospital Surgical Grand Round 19 June 2004.
Haley Hyde Jessica Fordham Jena Hamm  Colorectal cancer is a leading cause of cancer related deaths every year.  150,000 Americans will be diagnosed.
Clinical Practice Screening for Colorectal Cancer David A. Lieberman, M.D. N Engl J Med Volume 361(12): September 17, 2009.
Update on Colon Cancer Screening and Prevention
Bowel Screening in Scotland – Current Challenges and Possible Solutions Prof. Bob Steele Ninewells Hospital, University of Dundee.
Benchmarking For Colonoscopy
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
Andreas Adler Charité Medical University of Berlin, Virchow Clinic Campus Central Interdisciplinary Endoscopy Unit Narrow Band versus Conventional Endoscopic.
Colonoscopy; Surveillance Indications
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
COMPARING YIELD AND COST OF FOBT AND FS IN AN AVERAGE RISK POPULATION: RESULTS AFTER 2 SCREENING ROUNDS N.Segnan MD, Ms Epi Center for Cancer Prevention.
Population Screening for Colorectal Cancer - update of evidences
COLONOSCOPY QUALITY: FROM ASSESSMENT TO IMPLEMENTATION
Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based fecal occult blood testing: a population-based controlled trial.
PREPARED BY Colorectal Cancer Programme Screening for Colorectal Cancer A/P Susan Parry, Gastroenterologist, CD MOH Bowel Cancer Programme.
Brian Cox Research Associate Professor: Cancer epidemiology and screening University of Otago Hugh Adam Cancer Epidemiology Unit Department of Preventive.
The effects of inadequate preparation quality for colonoscopy Eric Sherer and Michael Catlin August 20 th, 2010 HSR&D Work-in-Progress 1.
Robert E. Schoen, MD MPH Associate Professor of Medicine and Epidemiology Division of Gastroenterology University of Pittsburgh Organizing Colorectal Cancer.
Screening for Colorectal Cancer (CRC) Nov, 2007 A Aljebreen, FRCPC Division of Gastroenterology KKUH, Riyadh.
Colon Cancer Screening- Rationale Behind the Guidelines.
Serrated Polyps of the Colon Aaron Sinclair, MD University of Kansas School of Medicine – Wichita Department of Family and Community Medicine Wesley Family.
Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.
Sessile Serrated Adenomas: A Case Presentation Kevin Witt, PGY3 Justin Whitt, MD IU Health Ball Memorial Family Medicine Residency.
Yield of colonoscopy for advanced neoplasia in a population-based setting Bernard DENIS, Jacques PICOT, Jean François VIES, Marjorie MUSSO, Paul François.
Do all colorectal polyps require pathological examination? Aim To assess whether it is possible to omit the pathological examination of some polyps without.
CT Colonography vs Colonoscopy for the Detection of Advanced Neoplasia David H. Kim, M.D., Perry J. Pickhardt, M.D., Andrew J. Taylor, M.D., Winifred K.
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
Towards Global Eminence K Y U N G H E E U N I V E R S I T Y Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society.
Quality of Colonoscopy Using an endoscopic database to measure and improve quality AAPCE Memphis- November 5, 2011 David Lieberman MD Chief, Division of.
Interval Colorectal Cancer 전임의 남지혁 Comparison of the Observed Incidence of Colorectal Cancer in the National Polyp Study Cohort with That.
1 Yize R. Wang, MD, PhD, John R. Cangemi, MD, Edward V. Loftus Jr, MD and Michael F. Picco, MD, PhD Am J Gastroenterol 2013;108:444–449 F1 김혁 / Prof. 김효종.
GASTROINTESTINAL ENDOSCOPY Volume 78, No. 3 : 2013 F1 김태영
R4 채정민 / Prof 이창균. INTRODUCTION colonoscopy is a widely used screening tool for colorectal cancer adenoma detection rate (ADR) important quality indicator.
CLinical EValuation of the EndoRings: “The CLEVER study” Interim results of a randomized, multicenter, tandem colonoscopy study Introduction Adenomas can.
Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
Do we need colonoscopy in patients with gastric adenoma? The risk of colorectal adenoma in patients with gastric adenomas R3 Kim Jungwook Moon Hee Yang,
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal- Cancer Deaths N ENG J MED ;8 : Ann G. Zauber, Ph.D, Sidney J. Winawer,
USPSTF Colorectal Cancer Screening Guidelines: What’s New?
Clinical process indicators
Colon Cancer Sreening Recommendations
بسم الله الرحمن الرحيم.
Colorectal Cancer Screening Guidelines
Mammograms and Breast Exams: When to start /stop mammograms
A Quality improvement initiative
27th Annual Winter CME Conference
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Full-Spectrum Endoscopy Improves Adenoma Detection Compared to Conventional Colonoscopy PLUS Right-Colon Examination With Scope Retroflexion: A Randomized,
Jasper Vleugels PhD-student AMC
Cancer screening PROF .MAZIN AL-HAWAZ.
A Visual Tour of Effective Colonoscopy
Improving Quality Measures for Colonoscopy and CRC Prevention
CRC Screening and Quality of Colonoscopy
Feeling Rushed? Does Late Start Time Predict Poor Quality Colonoscopy?
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
A Visual Tour of Effective Colonoscopy
Citation: Cancer Care Ontario
Colonoscopy in crc screening
Presentation transcript:

Risks of interval colorectal cancer in a FIT-based screening program 2018.9.27 목요세미나 Risks of interval colorectal cancer in a FIT-based screening program 서울대학교병원 이 현 정

Prevention of CRC by colonoscopy Colonoscopic polypectomy → CRC mortality 53% reduction CRC screening & colonoscopy → CRC incidence & mortality ↓ Zauber AG, et al. N Engl J Med 2012; Patel SG, et al. CGH 2014

Interval colorectal cancer Colorectal cancer diagnosed after a screening or surveillance exam in which no cancer is detected, and before the date of the next recommended exam Interval CRC ≒ Missed CRC ≒ post colonoscopy CRC (PCCRC) Prevalence: 1.8 – 9.0% Location Proximal interval CRC 6.5% Distal interval CRC 2.9% 2.4 times more in proximal than distal compared with sporadic cancer Singh S et al, Am J Gastroenterol 2014; Sanduleanu S, et al. Gut 2015

Risk factors Patient-related factors Endoscopy-related factors Age (OR 1.15, > 65 – 70 vs < 65 – 70) Family history of CRC (OR 1.6) Diverticular disease (OR 4.3) Higher Charlson comorbidity index (OR 2.0) Polypectomy on their index colonoscopy (OR 1.6) Endoscopy-related factors Non-gastroenterologist (Internist of family physician) (OR 1.53) Lower polypectomy rate & lower procedure completion rates Biology-related factors Female no more likely than males (OR 1.06) FHx: any first-degree relative or only those occurring at age < 50 year Pathway/gene Frequency within (%) Sporadic CRC Interval CRC CIN ≤85 ND MSI 10-15 25-30 CIMP 30-33 30-57 BRAF 5-22 22-28 KRAS 33-51 13-23 Singh S et al, Am J Gastroenterol 2014; Patel SG, et al. CGH 2014; Cisyk AL, et al. Dig Dis Sci 2014

Etiology of interval CRCs Missed lesion Incomplete resection Incomplete colonoscopy Newly developed cancer (rapid progression) Patel SG, et al. CGH 2014; Le Clercq CM, et al. Gut 2014

Missed lesions Etiology (1) N=6 (465 patients) Adenoma miss rate: 6~27% Polyp size ↓ → miss rate ↑ CRC 5%, polyp 22-28%, adenoma 20-24% Van Rijn, et al. Am J Gastroenterol 2006

Incomplete resection Etiology (2) Incomplete resection rate Overall 10.1% 10-20mm vs. <10mm: 17% vs 6.8% SSA/P vs. adenoma: 31% vs. 7.2% Pohl H, et al. Gastroenterol 2013

Incomplete colonoscopy Etiology (3) Impact of suboptimal bowel preparation Adenoma miss rate: 42% Advanced adenoma miss rate: 27% Cecal intubation Cecal intubation rate ↑ ADR ↑ Protection of Rt. Colon cancer Lebwohl B, et al. Gastrointes Endosc 2011; Baxter NN, et al. Gastroenterol 2011

Newly developed cancer Etiology (4) SSA/P with dysplasia is believed to play the important role in interval CRC Serrated pathway SSA/P: rapid progression, missed lesion, incomplete resection Rex et al, Am J Gastroenterol 2012

Issues to be resolved in interval CRC Procedural factors and biological features may be responsible for the occurrence of interval CRC, yet data regarding precise contribution and prevention are limited There are insufficient data on high risk patients for interval CRC who may need intensive surveillance Little is known about data on interval CRC especially in FIT-based screening program Clinical data on interval CRC in eastern countries are also lacking

Population-based muticentre study in South-Limburg, the Netherlands from Jan 2001 to Dec 2010 Interval CRC definition: CRC diagnosed within 5 years after an index colonoscopy Precise clinical and histopathology records including photographic documentation of CRC In T1 CRC, more often flat in PCCRCs than prevalent CRCs : 30.8% (8/26) vs 14.0% (68/486), p = 0.040 age-adjusted OR 2.78, 95% CI 1.16 to 6.68)

Non-polypoid (flat or depressed) colorectal adenomas contribute to the development of PCCRCs due to overlooked lesions, a more challenging resection or perhaps a more aggressive biological behavior The majority of PCCRCs (86%) would most probably have been preventable, being caused by missed or incompletely removed lesions and inadequate examination or surveillance and quality improvements are needed Limitation Lack of biological feature (eg, serrated pathway) Subgroup at high risk for interval CRC who may need intensive surveillance

Biennial FIT was offered to average-risk subjects aged 50–69 years FIT positivity: 5.2% 대장내시경 수검율: 51.4% Total IC N=162 Large, population-based data on subjects who received complete total colonoscopy after positive FITs in the Taiwanese Nationwide CRC Screening Program from 2004 to 2009 Biennial FIT was offered to average-risk subjects aged 50–69 years Participants with positive tests were referred for colonoscopy by certified endoscopists (gastroenterologist or surgeon) within 6 months FIT cut-off: 20ugHb/g feces Interval CRC incidence rate: 1.14 per 1000 PY Interval CRC rate 7.35% (162/2203)

Inadequate quality of colonoscopy (such as low ADR) is still the main cause responsible for the risk of IC Missed lesion (85%), Incomplete resection (2%), Newly developed cancer (13%) A high baseline FHbC was also associated with a significantly higher risk of developing IC, even in the subjects with negative colonoscopy Second look endoscopy Interval FIT before the next round of screening Limitation Accuracy of FIT test Difference in characteristic of interval CRC between in eastern and western countries (Proximal vs distal 39% vs 61%) FIT sensitivity for CRC 79%, specificity 94% (2014 meta-analysis) FIT 수검율 (33.3%), FIT -> colonoscopy 수검율 (28.8%) False FIT result..

Interval FIT before scheduled surveillance 1736 patients with a family history or past neoplasia; they received at least 2 colonoscopy examinations and were followed for a total of 8863 years An FIT was offered yearly, in the interval between colonoscopies; if results were positive, the colonoscopy was performed earlier than scheduled Interval FIT testing in a high-risk colonoscopy surveillance program is useful as a strategy for detecting missed or rapidly developing lesions But, lack of data on findings and quality of index colonoscopy 1071 (61.7%) participated in FIT test and average 1.8 FITs were done FIT sensitivity : 86% for CRC (12/14), 63% for AA (60/96) Reduction in time to diagnosis : 25 months earlier for cancer 24 months earlier for advanced adenoma Lane JM, et al. Gastroenterol 2010

Interval CRC in multiple rounds of FIT Average-risk participants in pilot FIT-based biennial CRC screening program conducted between 2006 and 2014 in Netherlands (50 – 74 years) Factors to be considered in a FIT-based CRC screening program FIT test characteristics (sensitivity and specificity) Adherence to screening with FIT Follow-up colonoscopy in persons who are FIT-positive (In Korean study, uptake of colonoscopy in FIT-positive participants was only 28.8%) FIT interval cancer 23% FIT positivity: 16% Colonoscopy 92% adherence Van Der Vlugt M, et al. Gastroenterol 2017; Lee CK, et al. Cancer Res Treat 2018

Different characteristics in eastern countries In Korean study, Proximal colon 32.7% vs 17.4% (interval CRC vs screen-detected CRC) Distal colon 61.9% vs 79.0% (interval CRC vs screen-detected CRC) Biologic differences? Le Clercq CM, et al. Gut 2014 OR for proximally located interval cancer = 1.24 Chiu SY, et al. Gut 2017 Lee CK, et al. Cancer Res Treat 2018

Conclusion The majority of interval CRC may probably have been preventable, being caused by missed or incompletely removed lesions and inadequate examination or surveillance Fecal hemoglobin, independently of quality of colonoscopy, is also a significant predictor for interval CRC in subjects who received complete colonoscopy after positive FIT Further study using big Annual FIT-based CRC screening program in Korea (45 – 80 years) Accuracy of FIT test Sensitivity 79%, specificity 94% Factors associated false FIT results : age, gender, NSAIDs, anticoagulants, family hx, lipid profile, co-morbidity Factors to follow-up colonoscopies for patients with positive FIT results Risk of interval CRC in a FIT-based screening program in Korea The role of interval FIT tests in detection of interval CRC FIT 수검율 33.3% (2017년)

경청해 주셔서 감사합니다 !